YU Jia, LUO Bao-xiang, WANG Xiao-bin, ZHENG Xia, ZHAN Ping. Clinical Analysis of 166 Inpatients with Drug Eruption[J]. Chinese Journal of Pharmacovigilance, 2012, 9(10): 619-621.
[1] 赵辨.临床皮肤病学[M].第3版.南京:江苏科学技术出版社,2001:620-626. [2] 张学军.皮肤性病学[M].第7版.北京:人民卫生出版社,2009年,120-124. [3] 李慧,刘万红.药疹350例临床分析[J].临床合理用药,2010,6(3):55-56. [4] Thong B Y, Tan T C. Epidemiology and risk factors for drug allergy[J]. Br J Clin Pharmacol. 2011,71(5):684-700. [5] Kamatani N. The future directions of pharmacogenomics[J].Nihon Shinkei Seishin Yakurigaku Zasshi.2011,31(4):149-54. [6] Lee M T, Hung S I, Wei C Y,et al. Pharmacogenetics of toxic epidermal necrolysis[J].Expert Opin Pharmacother.2010,11(13):2153- 2162. [7] 邱敏蕾,顾军.300例住院药疹患者临床特征分析[J]. 中国中西医结合皮肤性病学杂志,2009,8(5)271-274. [8] 李焕德,程泽能. 临床药学[M].北京:人民卫生出版社,2006:210-211.